Company Profile
AlphaMed Press
Company Overview
AlphaMed Press was founded in Ohio in 1983 and relocated to Durham, North Carolina 22 years later. AlphaMed Press publishes two internationally renowned peer-reviewed journals: THE ONCOLOGIST®, a monthly cancer medicine journal for those entrusted with cancer patient care, and STEM CELLS®. Approaching its 28th year, STEM CELLS is the oldest journal in the fast-paced area of stem cells and regenerative medicine. Not only is it the first journal to be devoted to this promising research, it remains a the top tier of peer-reviewed monthly journals for this discipline.
In April 2011, AlphaMed Press announces the launch of a major peer-reviewed journal, STEM CELLS Translational Medicine (SCTM), answering an acknowledged need within the research and clinical communities for comprehensive coverage of stem cell science, stem cell-based regenerative medicine and tissue engineering, stem cell-based predictive toxicology, and cancer stem cell investigation.
STEM CELLS Translational Medicine will publish high-impact, peer-reviewed articles that will significantly advance the clinical utilization of stem cell molecular and cellular biology by bridging stem cell research and clinical trials. In addition to original manuscripts, case studies, and commentaries this unique journal will encourage researchers to submit data from their negative clinical trials for publication to rapidly share results that other researchers may find valuable.